Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Persistent response to vemurafenib in metastatic ameloblastoma with BRAF mutation: a case report.

Subjects: Ameloblastoma*/Ameloblastoma*/Ameloblastoma*/drug therapy ; Ameloblastoma*/Ameloblastoma*/Ameloblastoma*/pathology ; Ameloblastoma*/Ameloblastoma*/Ameloblastoma*/secondary

  • Source: Journal of medical case reports [J Med Case Rep] 2019 Jul 25; Vol. 13 (1), pp. 245. Date of Electronic Publication: 2019 Jul 25.Publisher: BioMed Central Country of Publication: England NLM ID: 101293382 Publication Model: Electronic Cited Medium: Internet ISSN: 1752-1947

تفاصيل العنوان

×
Report

HD IL-2 + Vemurafenib in Patients With BRAF Mutation Positive Metastatic Melanoma (PROCLIVITY01)

  • Source: A Multi-Center Study of High Dose Aldesleukin (Interleukin-2) + Vemurafenib Therapy in Patients With BRAFV600 Mutation Positive Metastatic

تفاصيل العنوان

×
Report

Vemurafenib Combined With Whole Brain Radiation Therapy or Radiosurgery in Patients With BRAF Mutation-Positive Melanoma and Brain Metastases

  • Source: Phase I Study of Vemurafenib Combined With Whole Brain Radiation Therapy (WBRT) or Radiosurgery (SRS) for Melanoma Patients With BRAF

تفاصيل العنوان

×
  • 1-10 ل  219 نتائج ل ""BRAF mutation""